Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04316936 · ClinicalTrials.gov registry record · Phase 4
Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery
A Phase 4 study of Cataract Surgery, sponsored by Silverstein Eye Centers.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04316936 is a Phase 4 study of Cataract Surgery that has completed, run by Silverstein Eye Centers. The registered enrollment target is 15 participants, below the 144-participant average among 7 other Cataract Surgery trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04316936, a Phase 4 study of Cataract Surgery, has completed, sponsored by Silverstein Eye Centers.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will evaluate the efficacy of Omidria and Dexycu, Omidria and Dextenza, and Omidria and prednisolone acetate 1% in the resolution of post-operative inflammation and pain following cataract surgery.
Conditions Studied
Interventions
- DRUG Prednisolone Acetate 1%
- DRUG Omidria
- DRUG Dextenza (dexamethasone ophthalmic insert) 0.4mg
- DRUG Dexycu, 9% Intraocular Suspension
Study Locations (1)
Missouri
- Silverstein Eye Centers - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-12-10 |
| Est. Completion | 2020-12-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04316936
The ClinicalTrials.gov registry entry for NCT04316936 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 7 other Cataract Surgery trials with a reported enrollment target (90% lower). The listed sponsor is Silverstein Eye Centers, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract Surgery appearing as the primary indexed condition, and to 4 interventions - of which Prednisolone Acetate 1% is the first listed.
NCT04316936 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04316936 about?
NCT04316936 is a clinical study titled "Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery". This research will evaluate the efficacy of Omidria and Dexycu, Omidria and Dextenza, and Omidria and prednisolone acetate 1% in the resolution of post-operative inflammation and pain following cataract surgery.
What is the current status of trial NCT04316936?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2019-12-10. Estimated completion is 2020-12-23.
What conditions does trial NCT04316936 study?
This clinical trial studies the following conditions: Cataract Surgery.
What interventions are being tested in trial NCT04316936?
The interventions under investigation include: Prednisolone Acetate 1% (DRUG), Omidria (DRUG), Dextenza (dexamethasone ophthalmic insert) 0.4mg (DRUG), Dexycu, 9% Intraocular Suspension (DRUG).
Who is sponsoring clinical trial NCT04316936?
This trial is sponsored by Silverstein Eye Centers, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04316936 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral vs IV Sedation for Cataract Surgery in Older Adults
RECRUITING · Phase 4
-
Remimazolam for Cataract Surgery
RECRUITING · Phase 4
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients
RECRUITING
-
Efficacy and Safety of Bromfenac Ophthalmic Solution
COMPLETED · Phase 2
-
Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.